IMI plc Acquires Adaptas Solutions from Ampersand Capital Partners for $271M

Adaptas Solutions Acquires Cadence Fluidics

December 7, 2020

Medical Devices

Adaptas Solutions, a portfolio company of Ampersand Capital Partners, has acquired Cadence Fluidics to broaden its product family of fluidic modules and custom valve solutions for life-science OEM instrument manufacturers. Cadence's manufacturing will be transitioned into Adaptas' 90,000 sq. ft. Palmer, Massachusetts campus; financial terms were not disclosed.

Adaptas Solutions Acquires Applied Kilovolts and Analytical Instrumentation Business from L3Harris Technologies

February 26, 2020

Medical Devices

Adaptas Solutions, a portfolio company of Ampersand Capital Partners, agreed to acquire L3Harris Technologies' Applied Kilovolts and Analytical Instrumentation business to expand its mass spectrometry component offering, add the CeraMAX product line and broaden its global manufacturing footprint (including Europe). Financial terms were not disclosed; the transaction was announced in February 2020 and expected to close mid-2020.

Ampersand Capital Partners Acquires Specac Ltd.

March 13, 2024

Manufacturing

Ampersand Capital Partners, a Boston-based private equity firm focused on healthcare and life sciences, has acquired Specac Ltd., a UK-based designer and manufacturer of FTIR spectroscopy accessories and sample preparation solutions. The acquisition will support Specac's growth trajectory and leverage Ampersand's experience in life-sciences-oriented lab products and OEM channels.

Ampersand Capital Partners Acquires Peptides International and Merges It with New England Peptide

December 16, 2019

Biotechnology

Ampersand Capital Partners has acquired Peptides International and merged it into its existing portfolio company, New England Peptide, creating a combined provider of custom and catalog peptide synthesis services. The transaction is an add-on to Ampersand’s New England Peptide platform to expand scale, capabilities, and customer relationships across pharmaceutical, biotech and academic markets.

Ampersand Capital Partners Provides Growth Equity to NanoImaging Services

June 12, 2023

Healthcare Services

NanoImaging Services (NIS), a San Diego–based provider of cryo-electron microscopy services to the pharmaceutical and biotechnology industries, received a growth equity investment from Ampersand Capital Partners. The financing — which included participation by members of NIS management — will fund worldwide growth initiatives including expanding microscope capacity and adding complementary services to support structural biology and nanoparticle characterization.

Boyne Capital Acquires Adapt Laser Systems

February 6, 2019

Industrial Services

Boyne Capital has acquired Adapt Laser Systems, the exclusive North American sales, distribution and technical services partner to German OEM CleanLASER. Headquartered in Kansas City, Missouri, Adapt Laser provides laser cleaning and surface-preparation equipment and services to aerospace, automotive, defense and other industrial end-markets; the transaction represents a platform investment by Boyne (BCM Fund I) to support growth and expand market adoption of laser cleaning solutions.